Clinical Trial Update: A Study to Assess the Persistence of a GBS Antibody in Women Previously Immunized With a GBS Vaccine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the duration of GBS antibody persistence in women previously immunized with a GBS vaccine; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Disease

Drugs mentioned

• GBS vaccine (Group B Streptococcus vaccine)

Snippet

Sponsor: Novartis | Conditions: Group B Streptococcus (GBS) Disease | Phase 1 | Status: COMPLETED